[Successively improved prognosis in erythrocyte immunization].
Prognosis in cases of erythrocyte immunisation has improved continuously over the past decades. Morbidity and mortality have been reduced by improvements in management, including screening programmes, non-invasive ultrasound evaluation and invasive procedures. The article provides an outline of the latest developments in the management of erythrocyte immunisation, and several controversial issues are discussed, such as antibody screening, strategies for the reduction of antibody titres, and the organisation of care.
Westgren
M
M
Kliniskt genetiska avdelningen, Karolinska sjukhuset, Stockholm.
Bui
T H
TH
Grunewald
C
C
Kublickas
M
M
Kalsson
A
A
Wolff
K
K
Shanwell
A
A
D000751:Anemia, Neonatal / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D000906:Antibodies / Q000032:analysis; D002497:Centralized Hospital Services; D004899:Erythroblastosis, Fetal / Q000175:diagnosis / Q000235:genetics / Q000517:prevention & control; D017707:Erythrocyte Transfusion; D004912:Erythrocytes / Q000276:immunology*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008403:Mass Screening; D011247:Pregnancy; D011379:Prognosis; D012041:Regional Medical Programs; D012203:Rh Isoimmunization / Q000175:diagnosis / Q000235:genetics / Q000517:prevention & control
D000906:Antibodies
Successivt förbättrad prognos vid erytrocytimmunisering.